Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer, Secondary cancers
Closed
Phase 3
This trial is looking at adding capivasertib to abiraterone for men with prostate cancer. It is for men whose:
cancer has recently been diagnosed and has spread elsewhere in the body. This is called advanced or metastatic prostate cancer.
cancer cells have low levels of a protein called PTEN
Recruitment start: 18 March 2021
Recruitment end: 31 October 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Choudhury
AstraZeneca
Last reviewed: 1 November 2023
CRUK internal database number: 17683
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
